EGFR Mutations in Asian Patients with Advanced Lung Adenocarcinoma

被引：17
|
作者：
Liam, Chong-Kin [1 ]
Pang, Yong-Kek [1 ]
Poh, Mau-Ern [1 ]
机构：
[1] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2014年 / 9卷 / 09期
关键词：
D O I：
10.1097/JTO.0000000000000251
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E70 / E71
页数：2
相关论文
共 50 条
  • [21] Detecting EGFR Mutations from Plasma cfDNA in Lung Adenocarcinoma Patients
    Hung, M.
    Lung, J.
    Lin, Y.
    Fang, Y.
    Tsai, Y.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [22] KRAS and EGFR mutations coexisting in lung adenocarcinoma
    Vitor Sousa
    Ana Alarcão
    Patricia Couceiro
    Maria R Silva
    Maria J d’Aguiar
    Lia Teixeira
    Lina Carvalho
    [J]. BMC Proceedings, 4 (Suppl 2)
  • [23] Prevalence, Clinicopathologic Characteristics, and Molecular Associations of EGFR Exon 20 Insertion Mutations in East Asian Patients with Lung Adenocarcinoma
    Pan, Yunjian
    Zhang, Yang
    Li, Yuan
    Hu, Haichuan
    Wang, Lei
    Li, Hang
    Wang, Rui
    Ye, Ting
    Luo, Xiaoyang
    Zhang, Yiliang
    Li, Bin
    Cai, Deng
    Shen, Lei
    Sun, Yihua
    Chen, Haiquan
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S490 - S496
  • [24] Prevalence, Clinicopathologic Characteristics, and Molecular Associations of EGFR Exon 20 Insertion Mutations in East Asian Patients with Lung Adenocarcinoma
    Yunjian Pan
    Yang Zhang
    Yuan Li
    Haichuan Hu
    Lei Wang
    Hang Li
    Rui Wang
    Ting Ye
    Xiaoyang Luo
    Yiliang Zhang
    Bin Li
    Deng Cai
    Lei Shen
    Yihua Sun
    Haiquan Chen
    [J]. Annals of Surgical Oncology, 2014, 21 : 490 - 496
  • [25] Combination of Chemotherapy and Gefitinib as First-Line Treatment of Patients with Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations
    Jin, Bo
    Niu, Yanjie
    Zhang, Yanwei
    Chu, Tianqing
    Gu, Aiqin
    Pei, Jun
    Han, Baohui
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S646 - S646
  • [26] EGFR kinase domain mutations, but not copy number, predict response to erlotinib and gefitinib in patients with advanced lung adenocarcinoma
    Sholf, L. M.
    Janne, P. A.
    Jackman, D. M.
    Joshi, V. A.
    Lindeman, N. I.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (05): : 692 - 692
  • [27] Effect of thoracic radiotherapy dose on the prognosis of advanced lung adenocarcinoma harboring EGFR mutations
    Hongyue Qin
    Jiaojiao Ke
    Shuai Dong
    Huani Li
    Kunli Zhu
    Shuai Fu
    Qian Shao
    Zhenxiang Li
    [J]. BMC Cancer, 22
  • [28] Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma
    Coco, Simona
    Truini, Anna
    Vanni, Irene
    Genova, Carlo
    Rosano, Camillo
    Dal Bello, Maria Giovanna
    Alama, Angela
    Vene, Roberta
    Rijavec, Erika
    Barletta, Giulia
    Biello, Federica
    Boccardo, Francesco
    Grossi, Francesco
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (06) : E50 - E52
  • [29] Efficacy and safety of afatinib in a Chinese population with advanced lung adenocarcinoma with sensitive EGFR mutations
    Wang, Shouzheng
    Xing, Puyuan
    Yang, Ke
    Hao, Xuezhi
    Ma, Di
    Mu, Yuxin
    Li, Junling
    [J]. THORACIC CANCER, 2019, 10 (06) : 1461 - 1468
  • [30] Effect of thoracic radiotherapy dose on the prognosis of advanced lung adenocarcinoma harboring EGFR mutations
    Qin, Hongyue
    Ke, Jiaojiao
    Dong, Shuai
    Li, Huani
    Zhu, Kunli
    Fu, Shuai
    Shao, Qian
    Li, Zhenxiang
    [J]. BMC CANCER, 2022, 22 (01)
12345